This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2017-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2020
Title: **Innovator Profile: Linda M. Suen**
Introduction
Linda M. Suen is a prominent inventor based in Philadelphia, PA, with a focus on developing innovative solutions in the medical field. She holds two patents that contribute to the understanding and treatment of critical disorders affecting the central nervous system. Her work aims to pave the way for new therapeutic options for patients suffering from various cognitive impairments.
Latest Patents
Linda's latest patents include groundbreaking compounds designated as substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors. These compounds are particularly significant as they are intended for use in preventing, treating, or ameliorating diseases, especially those related to cognitive impairments in Alzheimer's disease, Parkinson's disease, and schizophrenia. Additionally, her second patent similarly addresses allosteric modulators of nicotinic acetylcholine receptors with the same focus on treating central nervous system disorders, and also targets L-DOPA induced-dyskinesia and inflammation.
Career Highlights
Throughout her career, Linda has worked with renowned pharmaceutical companies including Merck Sharp & Dohme Corporation and Merck Sharp & Dohme Corp. Her experience in these prestigious organizations has significantly shaped her innovative journey and contributed to her findings in the field of medicinal chemistry.
Collaborations
Linda M. Suen has had the opportunity to collaborate with talented individuals in her career, including Brendan M. Crowley and Thomas J. Greshock. These collaborations have not only enriched her expertise but also facilitated a vibrant exchange of ideas that promotes research and development in therapeutic innovations.
Conclusion
Linda M. Suen’s contributions to the field of medicinal chemistry through her patents exemplify her commitment to improving healthcare outcomes. Her work continues to inspire future innovations in treating complex neurological disorders, highlighting the importance of research and development in enhancing patients' lives.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile